Aster DM board revamp post QCIL merger: 4 directors, IR head exit
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and in line with its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aster DM Healthcare is revamping its board after the Quality Care India merger. Four directors resigned effective July 1, 2026, including two independents and two non-executives. Chief IR and M&A Officer Hitesh Dhaddha also resigned effective July 18. New appointments include Varun Khanna as Managing Director, Blackstone nominees Ganesh Mani and Ayshwarya Vikram, three new independent directors, and multiple new CEOs across India and Bangladesh operations.
Major board revamp post QCIL merger; fresh leadership from Blackstone and QCIL takes charge. Watch for governance continuity.